Earnings
Krystal Biotech Operating Profit Jumps 72%, But Net Income Falls On A Year-Ago Tax Windfall
A one-time $31.4 million tax benefit in 2025 turned a strong quarter into a profit decline, and a $400 million buyback follows.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
A one-time $31.4 million tax benefit in 2025 turned a strong quarter into a profit decline, and a $400 million buyback follows.
SEC Filings
Bitcoin mining sales shrank from $71.7 million a year earlier, and adjusted EBITDA turned negative at $10.0 million.
SEC Filings
The utility would use proceeds on commercial paper and part of a 364-day term loan, with a $300 million option for buyers.
SEC Filings
Greece becomes the seventh European nation to pick the jet, with the first delivery to the Hellenic Air Force due in 2027.
Earnings
The drugmaker's third-quarter product revenue hit $259.7 million, and it says current cash funds operations into cash flow positivity.
Deals
The restaurant-reservation unit changes hands under an August agreement, and Tripadvisor will provide services to the buyer for 12 months.
Earnings
The gene-therapy maker's operating income rose to $71.1 million, but a year-earlier tax benefit did not repeat.
Earnings
Pump lasers and optical circuit switches led the quarter, and the company forecast second-quarter revenue of $1.575 billion to $1.625 billion.
SEC Filings
The agency granted Priority Review to ifezuntirgene inilparvovec and tentatively plans an advisory committee meeting, uniQure said.
SEC Filings
The DNA-based RRP therapy cleared on a 12-month complete-response measure, and the FDA wants a confirmatory study protocol by the end of 2026.
Earnings
The aerospace supplier's adjusted EBITDA rose 60.9% to $10.9 million, while operating cash flow fell to $3.8 million on an inventory build.
SEC Filings
The company will show the mouse results at a Friday poster in Chicago and expects first human proof-of-concept data in the second half of 2027.